Insulet (NASDAQ:PODD) vs. EssilorLuxottica (OTCMKTS:ESLOY) Head to Head Review

Insulet (NASDAQ:PODD) and EssilorLuxottica (OTCMKTS:ESLOY) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership.

Institutional & Insider Ownership

0.0% of EssilorLuxottica shares are owned by institutional investors. 0.4% of Insulet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Volatility & Risk

Insulet has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, EssilorLuxottica has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500.

Profitability

This table compares Insulet and EssilorLuxottica’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Insulet	9.76%	24.36%	10.02%
EssilorLuxottica	N/A	N/A	N/A

Valuation & Earnings

This table compares Insulet and EssilorLuxottica”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.07 billion	9.61	$418.30 million	$3.45	82.01
EssilorLuxottica	$28.69 billion	5.04	$2.55 billion	N/A	N/A

EssilorLuxottica has higher revenue and earnings than Insulet.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Insulet and EssilorLuxottica, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	0	2	21	1	2.96
EssilorLuxottica	0	1	4	1	3.00

Insulet currently has a consensus target price of $381.75, indicating a potential upside of 34.93%. Given Insulet’s higher probable upside, analysts plainly believe Insulet is more favorable than EssilorLuxottica.

Summary

Insulet beats EssilorLuxottica on 8 of the 12 factors compared between the two stocks.

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

About EssilorLuxottica

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.